Neurovance, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Neurovance, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2011. It has reported private securities offerings to the US SEC, most recently $554,280 sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Neurovance at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2011

SEC CIK1544176

What does Neurovance do?

Private fundraising reported to the SEC

5 Form D notices; the most recent reported $554,280 sold (2017).

Frequently asked questions about Neurovance

Where is Neurovance headquartered?

Neurovance, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Neurovance do?

Neurovance, Inc. is a biotechnology company.

When was Neurovance founded?

The earliest incorporation on record for Neurovance, Inc. is in 2011, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences